Swipe om te navigeren naar een ander artikel
This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55–85 years) completed baseline depression and physical assessment. Those without self-reported cardiovascular events were followed prospectively for hospital admissions for angina, myocardial infarction and cerebral infarction (median 937 days). Across 5140 person-years of risk (N = 1692), there were 47 incident cardiovascular hospitalisations (2.8 %). Controlling for age and gender, interleukin (IL)-6, C-reactive protein (CRP), body mass index (BMI) and waist-to-hip ratio were associated with future cardiovascular events. Mediation analysis showed that CRP accounted for 8.1 % and IL-6 10.9 % of the effect of depression on cardiovascular events, and including the indirect effect in the model substantially reduced the direct relationship between depression and cardiovascular hospitalisations. BMI and waist-to-hip ratio accounted for indirect effects of 7.7 and 10.4 %, respectively. Inflammatory markers partly explain the association between depression and cardiovascular events, although other shared factors also likely contribute.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Beekman, A., Deeg, D. J. H., Van Limbeek, J., Braam, A. W., De Vries, M. Z., & Van Tilburg, W. (1997). Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in The Netherlands. Psychological Medicine, 27, 231–235. PubMedCrossRef
Davidson, K. W., Schwartz, J. E., Kirkland, S. A., Mostofsky, E., Fink, D., Guernsey, D., et al. (2009). Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). American Journal of Cardiology, 103, 755–761. PubMedCentralPubMedCrossRef
Food Standards Australia New Zealand. (2006). NUTTAB 2006 Australian Food Composition Tables. Canberra, ACT: Department of Health and Ageing, Australian Government.
Hemingway, H., Philipson, P., Chen, R., Fitzpatrick, N. K., Damant, J., Shipley, M., et al. (2010). Evaluating the quality of research into a single prognostic biomarker: A systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Medicine, 7, e1000286. PubMedCentralPubMedCrossRef
Jamrozik, K., Dobson, A., Hobbs, M., McElduff, P., Ring, I., D’Este, C., et al. (2001). Monitoring the incidence of cardiovascular disease in Australia. AIHW Cat. No. CVD 16. Canberra: Australian Institute of Health and Welfare.
Kuo, H.-K., Yen, C.-J., Chang, C.-H., Kuo, C.-K., Chen, J.-H., & Sorond, F. (2005). Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis. Lancet Neurology, 4, 371–380. CrossRef
Ladwig, K.-H., Marten-Mittag, B., Lowel, H., Doring, A., & Koenig, W. (2005). C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. European Heart Journal, 26, 2537–2542. PubMedCrossRef
National Health and Medical Research Council. (2001). Australian alcohol guidelines: Health risks and benefits. Canberra, ACT: Australian Government.
National Heart Lung and Blood Institute. (2006). Incidence and prevalence: 2006 chart book on cardiovascular and lung diseases. Retrieved April 30, 2013 from http://www.nhlbi.nih.gov/resources/docs/06a_ip_chtbk.pdf.
Pasco, J. A., Jacka, F. N., Williams, L. J., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., et al. (2010a). Clinical implications of the cytokine hypothesis of depression: The association between use of statins and asprin and the risk of Major Depression. Psychotherapy and Psychosomatics, 79, 323–325. PubMedCrossRef
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., et al. (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499–511. PubMedCrossRef
Radloff, L. S. (1977). The CES-D scale. Applied Psychological Measurement, 1, 385–401. CrossRef
Rallidis, L. S., Varounis, C., Sourides, V., Charalampopoulos, A., Kotakos, C., Liakos, G., et al. (2011). Mild depression versus C-reactive protein as a predictor of cardiovascular death: A three year follow-up of patients with stable coronary artery disease. Current Medical Research and Opinion, 27, 1407–1413. PubMedCrossRef
Skinner, H. A. (1982). Development and validation of a lifetime alcohol consumption assessment procedure. Toronto, ON: Addiction Research Foundation.
Sobell, M. B., Maisto, S. A., Sobell, L. C., Cooper, A. M., Cooper, T., & Sanders, B. (1979). Developing a prototype for evaluating alcohol treatment effectiveness. In L. C. Sobell, M. B. Sobell, & E. Ward (Eds.), Evaluating alcohol and drug abuse treatment effectiveness: Recent advances. New York: Pergamon Press.
Vaccarino, V., Johnson, B. D., Sheps, D. S., Reis, S. E., Kelsey, S. F., Bittner, V., et al. (2007). Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: The National Heart, Lung, and Blood Institute-Sponsored WISE Study. Journal of the American College of Cardiology, 50, 2044–2050. PubMedCrossRef
World Health Organization. (2008). The Global Burden of Disease 2004 Update. Switzerland: World Health Organization.
- The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations
Sarah A. Hiles
Amanda L. Baker
Theo de Malmanche
- Springer US